Search This Blog

Wednesday, August 28, 2019

Mirum Pharmaceuticals EPS misses by $4.79

Mirum Pharmaceuticals (NASDAQ:MIRM): Q2 GAAP EPS of -$5.31 misses by $4.79.
Cash, cash equivalents and investments of $100.3M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)